$210.00–$900.00Price range: $210.00 through $900.00
Retatrutide is an investigational peptide designed as a triple agonist targeting the GLP-1, GIP, and glucagon receptors—three key pathways involved in appetite regulation, glucose control, and energy expenditure. By simultaneously activating these receptors, retatrutide aims to enhance satiety, reduce caloric intake, improve insulin sensitivity, and increase metabolic rate. This multi-pathway approach differentiates retatrutide from single- or dual-agonist therapies and has generated significant interest in metabolic and obesity research.
Reviews
There are no reviews yet.